Sudeep Pharma Ipo
Sudeep Pharma IPO Review & Key Points
Review:
Peer Group Comparison
There are no peer group companies listed in India.
IPO Lead Managers aka Merchant Bankers
ICICI Securities Ltd.
IIFL Capital Services Ltd.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 25 | ₹14,825 |
| Retail Maximum | 13 | 325 | ₹1,92,725 |
| S-HNI Minimum | 14 | 350 | ₹2,07,550 |
| S-HNI Maximum | 67 | 1,675 | ₹9,93,275 |
| B-HNI Minimum | 68 | 1,700 | ₹10,08,100 |
| Investor Category | Share Offered | -% Shares |
| Anchor Investor | – Shares | -% |
| QIB (Ex. Anchor) | 75,46,376 Shares | 50% |
| NII Shares Offered | 22,63,912 Shares | 15% |
| Retail Shares Offered | 52,82,462 Shares | 35% |
| Anchor Bidding Date | November 20, 2025 |
| Anchor Investors List | |
| Shares Offered | 45,27,823 Shares |
| Anchor Size | 268.50 Cr. |
| lock-in period end date 50% shares (30 Days) | December 26, 2025 |
| lock-in period end date 50% shares (90 Days) | February 24, 2026 |
| IPO Open Date: | November 21, 2025 |
| IPO Close Date: | November 25, 2025 |
| Basis of Allotment: | November 26, 2025 |
| Refunds: | November 27, 2025 |
| Credit to Demat Account: | November 27, 2025 |
| IPO Listing Date: | November 28, 2025 |
| IPO Bidding Cut-off Time: | November 25, 2025 – 5 PM |
| Particular | Shares | % Share |
| Promoter Holding Pre Issue | 11,13,46,602 | 89.37% |
| Promoter Holding Post Issue | 11,29,48,626 | 76.15% |
| Purpose | Crores |
| Capital expenditure towards procurement of machinery for the production line located at Nandesari Facility I | 75.81 |
| General corporate purposes | – |
| Period Ended | Revenue | Expense | PAT | Assets |
| 2022 | ₹351.00 | ₹282.46 | ₹49.80 | ₹345.00 |
| 2023 | ₹438.26 | ₹352.28 | ₹62.32 | ₹420.11 |
| 2024 | ₹465.38 | ₹290.56 | ₹133.15 | ₹513.87 |
| 2025 | ₹511.33 | ₹328.48 | ₹138.69 | ₹717.17 |
| June 2025 | ₹130.08 | ₹86.00 | ₹31.27 | ₹922.26 |
| KPI | Values |
| ROE: | 28.13% |
| ROCE: | 29.82% |
| EBITDA Margin: | 39.70% |
| PAT Margin: | 27.63% |
| Debt to equity ratio: | 0.20 |
| Earning Per Share (EPS): | ₹12.78 (Basic) |
| Price/Earning P/E Ratio: | N/A |
| Return on Net Worth (RoNW): | 27.88% |
| Net Asset Value (NAV): | ₹45.86 |
| IPO Open Date | November 21, 2025 |
| IPO Close Date | November 25, 2025 |
| Face Value | ₹1 Per Equity Share |
| IPO Price Band | ₹563 to ₹593 Per Share |
| Issue Size | Approx ₹895 Crores |
| Fresh Issue | Approx ₹95.00 Crores |
| Offer for Sale: | Approx 1,34,90,726 Equity Shares |
| Issue Type | Book build Issue |
| IPO Listing | BSE, NSE |
| DRHP Draft Prospectus | |
| RHP Draft Prospectus |